October - 2018

Advent Access unveils Clinical Trial results at the American Society of Nephrology Kidney Week, 2018

The full results of Advent Access's First-In-Human Clinical Trial of the av-Guardian device was released at the American Society of...

Advent Access acquires Vwing™ Vascular Needle Guide to create leading portfolio of vascular access s

Advent Access is pleased to announce that we have acquired the global manufacturing and commercialization rights to the Vwing™ Vascular...

Check back soon

Once posts are published, you’ll see them here.

CE Mark Certificate for Pioneering av-Guardian™ Vascular Access System

Advent Access Receives ISO13485:2016 Certification, 2019

av-Guardian Assist in Haemodialysis, Shake It Up, CNBC, 2017

Advent Access selected to join Silicon Valley’s prestigious Stanford StartX community, 2019

Advent Access featured as one of the Top Stories on The Business Time, 2019

Advent Access unveils Clinical Trial results at the American Society of Nephrology Kidney Week, 2018

Advent Access acquires Vwing™ Vascular Needle Guide to create leading portfolio of vascular access s

Advent Access completes CE Mark submission for av-Guardian™ , 2018

Advent Access raises $2M in largest pre-series A financing for SEA med-tech firm, BioWorld, 2018

Advent Access Raises S$2.6 Million Pre-Series A Financing, PR Newswire, 2017

No tags yet.